State universities help build new cancer R&D complex in Texas

The Lone Star State's two biggest university systems are joining hands with the world-renowned M.D. Anderson Cancer Center to help design and staff a sprawling new cancer R&D complex.

Texas A&M and the University of Texas, intense rivals on the football field, will be working together to help build the National Center for Therapeutic Manufacturing, which is under construction at the A&M campus in College Station. The new, 153,000-square-foot center is intended to help speed development of new oncology therapeutics.

"M.D. Anderson and the NCTM are and will be the standard-setters in their research areas," said A&M Chancellor Michael McKinney, M.D. "Combining the capabilities of these two institutions will radically advance the search for a cancer solution in this generation."

The new center, which should open at the end of next year, is the jewel in the crown of the Texas Emerging Technology Fund, a state-backed effort aimed at spurring new cancer research. The Legislature allocated $200 million for the fund.

- here's the report
- and here's the story from the Houston Business Journal

Suggested Articles

MicuRx nabbed $7.78 million from a nonprofit focused on antimicrobial resistance to push its third antimicrobial program into human trials.

The FDA has placed a phase 1/2 trial of Passage Bio’s GM1 gene therapy on clinical hold pending further assessment of the risk of its delivery device.

Danish drugmaker Novo Nordisk is opening up its bleeding disorder trials five months after they were stopped.